Scafa, Stefano https://orcid.org/0009-0003-0707-7158
de Seta, Valeria https://orcid.org/0000-0001-8796-8775
Wang, Ruijia https://orcid.org/0000-0001-5018-5398
Sánchez López, Paula
Sánchez López, Andrea https://orcid.org/0009-0002-1453-6079
Varescon, Camille
Sakr, Icare
Bérard, Nadia https://orcid.org/0000-0002-2082-4221
Bole-Feysot, Lea
Deschenaux, Céline
Enderli, Ian
Thenaisie, Yohann https://orcid.org/0000-0002-9936-5821
Burri, Morgane
Merlos, Frédéric https://orcid.org/0009-0008-1018-5260
Fleury, Vanessa
Wicki, Benoit
Accolla, Ettore
Tziakouri, Andria
Hübsch, Cécile
Castro Jiménez, Mayte https://orcid.org/0000-0003-4165-4804
Bally, Julien F. https://orcid.org/0000-0002-0970-8844
Puiatti, Alessandro https://orcid.org/0000-0002-9745-1515
Lee, Kyuhwa https://orcid.org/0000-0002-3854-4690
Lorach, Henri
Collomb-Clerc, Antoine https://orcid.org/0000-0002-5687-0852
Bloch, Jocelyne https://orcid.org/0000-0002-6405-1590
Moraud, Eduardo M. https://orcid.org/0000-0002-6148-7065
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (TMSGI3_218471)
Article History
Received: 31 July 2025
Accepted: 29 April 2026
First Online: 15 June 2026
Competing interests
: J.B. and E.M.M. hold patents partially related to this work, on the use of real-time brain decoding to trigger and control neuromodulation therapies for improving gait after neurological disorders (US 10668280). J.B. is a founder and shareholder of ONWARD Medical, a company with potential interest in the findings reported in this work. J.F.B. has received honoraria from Medtronic in relation to educational courses. The other authors declare no competing interests.